Partner/Owner

Founder

Representative before the EPO

Employment test 1 - 10 employees
Company dna redl life science patent attorneys
no operation time available
Headquarter in Vienna
active in Legal Services and Matchmaking and Trading

We have observed 30 EP applications Gerda Redl has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 18, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12708846

NOVEL TUMOR MARKER DETERMINATION

IPC classification:
C12Q 1/68
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
PATENT GRANTED
EP12768859

REGULATABLE PROMOTER

IPC classification:
C07K 14/39, C07K 14/395, C12N 15/81
Applicant:
Lonza Ltd
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
EXAMINATION IN PROGRESS
EP12770156

METHOD OF GENERATING GENE MOSAICS IN EUKARYOTIC CELLS

IPC classification:
C12N 15/10, C12N 15/90
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12787454

BI-SPECIFIC ANTIBODIES FOR MEDICAL USE

IPC classification:
C07K 16/28
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
EXAMINATION IN PROGRESS
EP12730468

METHOD OF METABOLIC EVOLUTION

IPC classification:
C12N 15/10, C12N 15/90, C12P 7/26, C12P 17/06
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
APPLICATION WITHDRAWN
EP13714305

SECRETORY IMMUNOGLOBULIN COMPLEX

IPC classification:
A61K 38/17, A61K 39/395, C12N 5/10
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
EXAMINATION IN PROGRESS
EP12199502

Recombinant host cell for biosynthetic production of vanillin

IPC classification:
C12N 9/88, C12N 15/52, C12P 7/24
Applicant:
Rhodia Operations SAS
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Agent:
Laure Menville, Rhodia Operations SAS
Status:
EXAMINATION IN PROGRESS
EP13724297

SECRETORY IMMUNOGLOBULIN DEFICIENCY TREATMENT AND PROPHLAXIS

IPC classification:
A61K 39/395
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
PATENT GRANTED
EP13829360

NT-proCNP AS A BIOMARKER OF VASCULAR DISORDERS AND PREGNANCY COMPLICATION

IPC classification:
A61K 39/00, C07K 16/22, G01N 33/68
Applicant:
Otago Innovation Limited
Agent:
Pamela M. Tuxworth, J A Kemp
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
GRANT OF PATENT INTENDED
EP13785840

EXPRESSION SEQUENCES

IPC classification:
C07K 4/06, C07K 14/37
Applicant:
Lonza Ltd
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
PATENT GRANTED
EP13791949

EXPRESSION SYSTEM

IPC classification:
C07K 14/47, C12N 5/10, C12N 15/67, C12N 15/79
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
EXAMINATION IN PROGRESS
EP13792035

RECOMBINANT BISPECIFIC ANTIBODY BINDING TO CD20 AND CD95

IPC classification:
A61P 35/00, C07K 16/28
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
The patent has been granted
EP14164471

Medical use of artemisinin compounds and gephyrin agonists

IPC classification:
A61K 31/357, A61K 31/366, A61P 3/10, A61P 5/48, C12N 5/071
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14703783

MDR E. COLI SPECIFIC ANTIBODY

IPC classification:
A61K 39/395, A61P 31/04, C07K 16/12
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
EXAMINATION IN PROGRESS
EP13811203

CONSTITUTIVE PROMOTER

IPC classification:
C12N 15/81
Applicant:
Lonza Ltd
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
EXAMINATION REQUESTED
EP14724102

GASTRIN PEPTIDE IMMUNOGENIC COMPOSITION

IPC classification:
A61K 38/10, A61K 39/00, A61K 39/39
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
EXAMINATION IN PROGRESS
EP13173933

Method of generating gene mosaics

IPC classification:
C12N 15/10, C12N 15/90
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13728122

CROSS-REACTIVE STAPHYLOCOCCUS AUREUS ANTIBODY

IPC classification:
A61K 39/40, A61P 31/04, C07K 16/12
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14793035

CROSS-REACTIVE STAPHYLOCOCCUS AUREUS ANTIBODY SEQUENCES

IPC classification:
C07K 16/12
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
GRANT OF PATENT INTENDED
EP11805858

METHOD OF GENERATING INDUCED PLURIPOTENT STEM CELLS AND DIFFERENTIATED CELLS

IPC classification:
C12N 5/074, C12N 5/0789
Applicant:
University of Natural Resources and Applied Life Sciences, Vienna (Universität für Bodenkultur Wien)
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14845032

E. COLI SPECIFIC ANTIBODY SEQUENCES

IPC classification:
A61K 39/395, C07K 16/12
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
EXAMINATION REQUESTED
EP16201732

MDR E. COLI SPECIFIC ANTIGEN

IPC classification:
A61K 39/395, A61P 31/04, C07K 16/12
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
EXAMINATION REQUESTED
EP15825354

PREVENTING AND TREATING INFLAMMATORY SKIN DISEASES

IPC classification:
A61K 31/7105, A61P 17/00, A61P 17/06
Applicant:
Chaim Sheba Medical Center Tel HaShomer
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Agent:
Pearl Cohen Zedek Latzer Baratz UK LLP
Status:
EXAMINATION REQUESTED
EP15794549

RANKL-SPECIFIC AGENT FOR TREATING METASTATIC DISEASE

IPC classification:
A61K 38/19, A61K 39/395, A61P 35/04, C07K 14/705, C12Q 1/68, G01N 33/50
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
EXAMINATION REQUESTED
EP15750708

PREDICTING S. AUREUS DISEASE

IPC classification:
C12Q 1/68, G01N 33/569
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
EXAMINATION REQUESTED
EP15750404

CYCLIC PEPTIDES EXPRESSED BY A GENETIC PACKAGE

IPC classification:
C07K 1/04, C07K 7/50, C12N 15/10
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
EXAMINATION REQUESTED
EP16152731

TEMPERATURE-INDUCIBLE CRISPR/CAS SYSTEM

IPC classification:
C12N 15/11
Applicant:
ACIB GmbH
Applicant:
University of Natural Resources and Applied Life Sciences, Vienna (Universität für Bodenkultur Wien)
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
The application has been published
EP15805462

DOMAIN-EXCHANGED ANTIBODY

IPC classification:
C07K 16/00, C07K 16/28
Applicant:
Merck Patent GmbH
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
Request for examination was made
EP17174523

A NOVEL LIVE ATTENUATED SHIGELLA VACCINE

IPC classification:
A61K 39/02
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
Request for examination was made
EP15790526

ANTIBODIES TARGETING A GALACTAN-BASED O-ANTIGEN OF K. PNEUMONIAE

IPC classification:
C07K 16/12
Agent:
Gerda Redl, Redl Life Science Patent Attorneys
Status:
Request for examination was made

Please Sign in to use this feature